XTL BIopharmaceuticals Limited - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for XTL BIopharmaceuticals Limited. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

XTL BIopharmaceuticals Limited. The Group's principal activity is the acquisition, development and commercialization of therapeutics for the treatment of neurophatic pain and, Hepatitis C. The Company is a development stage biotechnology company. It does not yet have any product sales and expects to consume cash until products are commercialised. The Company's shares are traded on the London, New York and Tel Aviv Stock Exchange.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report